Knobbe Martens Elects New Partner Class
Newly elected partners come from a diversity of backgrounds, offices and practice areas within the firm IRVINE, Calif., January 13, 2025 – Knobbe Martens, a leading intellectual property law firm,...
Mauricio Uribe Comments on Recent FTC Data Breach Settlement in Bloomberg Law
In the Bloomberg Law article “FTC’s Marriott Data Breach Order Echoes States’ Right to Delete,” partner Mauricio Uribe offered his perspective on Federal and state privacy law compliance, specifically with...
FDA Issues Final Guidance on Transitioning from COVID-19 EUAs
The FDA recently announced release of final transition guidance documents for medical diagnostic devices targeting COVID-19. The transition guidance documents are intended to guide COVID-19 diagnostic device manufactures as their devices transition from Emergency Use Authorizations (EUAs). Just over three hundred EUAs were issued for diagnostic devices during the COVID-19 pandemic. In the announcement, the FDA characterized the issuance of EUAs as “proactive steps to help facilitate the availability of critical medical devices, including in vitro diagnostic tests.” Draft versions of the guidance documents were made available for public comment in December 2021.
